Systemic therapy:
Three patients received conventional chemotherapy. One patient received
Cisplatin and doxorubicin in our hospital. Two patients received
chemotherapy elsewhere and four patients received tyrosine kinase
inhibitors. Though Lenvatinib was recommended, all patients received
Sorafenib due to cost constraints.